RESULTS	Remission rates were significantly greater for desvenlafaxine 400 mg/day ( 32 % ) versus placebo ( 19 % ; p = .035 ) ; remission rates were 30 % for desvenlafaxine 100 mg/day ( p = .093 ) and 28 % for desvenlafaxine 200 mg/day ( p = .126 ) .\